Search the Archive

Heart Drug #274530

CBS Evening News for Wednesday, Nov 25, 1981
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio) Report introduced
REPORTER: Dan Rather

(DC) Proliferation of heart attacks in United States detailed; FDA (Food and Drug Administration) approval of drug Timolol as heart attack preventative examined. [FDA (Food and Drug Administration) commissioner Dr. Arthur Hull HAYES - notes drug's effectiveness.] Heart attack's course explained with animation from Timolol. [Dr. Kanu CHATTERJEE - reacts to situation.] [Dr. Ken. ROSEN anticipates approval of other drugs.] [Stanley WARSAW - cites drug's impact on day-to-day life.] Implications for future use on heart attack victims considered.
REPORTER: George Herman

Herman, George;
Rather, Dan

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.